NEJM This Week — October 20, 2022
Featuring articles on two randomized trials of ruxolitinib cream for vitiligo, blood-pressure and oxygen targets in comatose patients after cardiac arrest, intermittently scanned glucose monitoring, and on recognition for integrin research; a review article on myocarditis; a case report of a man with postoperative cardiogenic shock and diffuse rash; and Perspective articles on impending relief for Medicare beneficiaries, on on- and off-ramps of oncology accelerated approval, and on an emergency room trajectory.
